OakChart

Ashland Inc

ASHBasic Materials·Specialty Chemicals·USA·Mid·NYSE·Nov 10 • 3:59 PM ET

76.810.00 (0.00%)
2026-11-11 14:21 CET
Market cap
3,517.39 USD m
Revenue, TTM
1,863.00 USD m
Net income, TTM
4.00 USD m
Free cash flow, TTM
295.00 USD m
EPS diluted, TTM
0.09
P/E
882.87
Compare

Price

ASH against its 20, 50 and 200-day averages
2050200miss
60.0070.0080.003.6M7.1MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26ASHclose 76.8120-day 73.6850-day 71.77200-day 64.1976.81

3.4% under 79.50 on 6 Nov 2026. Last 15 sessions, 12.0% high to low

Profile

ASH
52-week range, 91% of the way up
48.0079.50

Ashland, Inc. is an additives and specialty ingredients company, which engages in the provision of architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical products. It operates through the following segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment is involved in pharmaceuticals, nutrition, nutraceuticals, agricultural chemicals, diagnostic films, and fine chemicals. The Personal Care segment consists of biofunctionals, microbial protectants, skin care, sun care, oral care, hair care, and household solutions. The Specialty Additives segment focuses on rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive, and various industrial markets. The Intermediates segment refers to production of 1,4 butanediol and related derivatives, including n-methylpyrrolidone. The company was founded in 1924 and is headquartered in Wilmington, DE.

IndexRUT
Employees2900
IPOMay 08, 1950
Beta0.36
ATR, 14d2.07
Rel volume0.00
Short float11.23%
Insider own1.29%
Inst own116.28%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap3.52B
Enterprise Value4.51B
Income4.00M
Sales1.86B
Book/sh40.84
Cash/sh10.48
Dividend Est.1.41 (1.84%)
Dividend TTM1.67 (2.17%)
Dividend Ex-DateSep 01, 2026
Dividend Gr. 3/5Y5.06% 7.75%
Payout1919.54%
Employees2900
IPOMay 08, 1950

Ratios

P/E882.87
Forward P/E15.60
PEG0.85
P/S1.89
P/B1.88
P/C7.33
P/FCF11.92
EV/EBITDA12.77
EV/Sales2.42
Quick Ratio1.89
Current Ratio2.96
Debt/Eq0.80
LT Debt/Eq0.78
Option/ShortYes / Yes

Earnings

EPS (ttm)0.09
EPS next Y4.92
EPS next Q0.38
EPS this Y27.53%
EPS next Y16.62%
EPS next 5Y18.46%
EPS past 3/5Y-70.41% -52.65%
Sales past 3/5Y-5.26% -2.47%
EPS Y/Y TTM106.07%
Sales Y/Y TTM2.08%
EPS Q/Q-150.00%
Sales Q/Q4.18%
EarningsNov 03 AMC
EPS/Sales Surpr.-12.12% -0.75%

Ownership

Insider Own1.29%
Insider Trans0.00%
Inst Own116.28%
Inst Trans-3.90%
ROA0.55%
ROE1.33%
ROIC0.12%
Gross Margin27.48%
Oper. Margin7.25%
Profit Margin0.21%
SMA204.25%
SMA507.03%
SMA20019.66%
Trades-

Technical

Shs Outstand45.79M
Shs Float45.20M
Short Float11.23%
Short Ratio8.21
Short Interest5.08M
52W High79.50 -3.38%
52W Low48.00 60.02%
Volatility3.63% 2.68%
ATR (14)2.07
RSI (14)65.16
Beta0.36
Rel Volume0.00
Avg Volume618.13K
Volume0

Performance

Perf Week5.19%
Perf Month8.52%
Perf Quarter2.80%
Perf Half Y35.42%
Perf YTD30.92%
Perf Year53.96%
Perf 3Y6.02%
Perf 5Y-23.44%
Perf 10Y45.15%
Recom1.46
Target Price82.45
Prev Close76.81
Price76.81
Change %0.00%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
May 06, 2026UpgradeSSeaport Research PartnersNeutral → Buy$75-2.4%
Dec 15, 2025UpgradeBBMO Capital MarketsMarket Perform → Outperform$71-7.6%
Sep 08, 2025InitiatedMMorgan StanleyEqual-Weight$60-21.9%
May 01, 2025DowngradeWWells FargoOverweight → Equal Weight
Mar 26, 2025UpgradeJJP MorganNeutral → Overweight$68 → $71-7.6%
Mar 05, 2025DowngradeSSeaport Research PartnersBuy → Neutral
Aug 08, 2024UpgradeJJP MorganUnderweight → Neutral$90 → $89+15.9%
Apr 11, 2024UpgradeWWells FargoEqual Weight → Overweight$100 → $112+45.8%
Mar 14, 2024UpgradeJJefferiesHold → Buy$100 → $126+64.0%
Mar 01, 2024InitiatedWWolfe ResearchOutperform$108+40.6%

Peers

Mkt cap
TickerCompanyMkt cap
EMNEastman Chemical Co7.56B
BCPCBalchem Corp5.50B
IOSPInnospec Inc1.91B
SXTSensient Technologies Corp5.15B
AVNTAvient Corp4.20B
IFFInternational Flavors & Fragrances Inc20.91B
MTXMinerals Technologies Inc1.92B
SCLStepan Co1.55B
CBTCabot Corp3.71B
DOWDow Inc22.85B

Insider trading

latest 14 of 28
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
MUSA OSAMA MSVP and CTOSep 21 '26Option Exercise69.0610,418719,46741,224Sep 23 04:30 PM
LAMPKIN ROBIN E.SVP, GC & SecretaryAug 11 '26Option Exercise74.581,806134,6916,825Aug 12 04:30 PM
MUSA OSAMA MSVP and CTOJul 29 '26Option Exercise57.961,26773,43530,806Jul 30 04:30 PM
Assis Alessandra FaccinSVP and GM, Life SciencesJul 27 '26Option Exercise66.383,215213,4129,099Jul 29 04:30 PM
MINICUCCI JAMES P.SVP and GM, Personal CareMay 08 '26Option Exercise55.014,310237,0938,567May 11 04:30 PM
Kulkarni Ashish KDirectorJan 21 '26Option Exercise0.002,11302,113Jan 22 04:30 PM
NOVO GUILLERMOChair of the Board and CEONov 17 '25Option Exercise49.606,122303,651143,412Nov 19 04:30 PM
Drury EileenSVP and Chief HRONov 17 '25Option Exercise49.6056728,1237,881Nov 19 04:30 PM
MUSA OSAMA MSVP and CTONov 17 '25Option Exercise49.6097648,41029,875Nov 19 04:30 PM
MUSA OSAMA MSVP and CTONov 14 '25Option Exercise51.512,091107,70729,616Nov 19 04:30 PM
MUSA OSAMA MSVP and CTONov 13 '25Option Exercise53.101,39373,96828,002Nov 19 04:30 PM
RICHARDSON SAMUELVP, Controller and PAONov 17 '25Option Exercise49.601075,3071,104Nov 19 04:30 PM
WHITAKER WILLIAMSVP, CFO & PFONov 17 '25Option Exercise49.601075,3072,082Nov 19 04:30 PM
LAMPKIN ROBIN E.SVP, Gen Counsel and Secrty.Nov 17 '25Option Exercise49.6023911,8545,095Nov 19 04:30 PM

Held by

AUM
TickerCompanyAUM
IJHiShares Core S&P Mid-Cap ETFAUM: 124.95B
AVUVAvantis U.S. Small Cap Value ETFAUM: 32.40B
IWMiShares Russell 2000 Index FundAUM: 78.30B
VTIVanguard Morningstar Total Stock Market ETFAUM: 689.41B
DFSVUS Small Cap Value Portfolio ETF Class SharesAUM: 8.54B
VBVanguard Morningstar Small-Cap ETFAUM: 79.96B
DFATU.S. Targeted Value Portfolio-ETF Class SharesAUM: 14.50B
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.82B
VXFVanguard Extended Market Index ETFAUM: 30.61B
IWNiShares Russell 2000 Value ETFAUM: 14.17B

News

latest 14 of 206
  • Ashland Misses On EPS As Hopewell Drag Offsets Record Specialty Margins; FY27 Outlook Rests On Plant Recovery (Earnings Whispers)
  • Ashland: Fiscal Q4 Earnings Snapshot (Associated Press)
  • Ashland reports fourth quarter and full-year fiscal 2026 results and issues outlook for fiscal 2027 (GlobeNewswire)
  • Ashland sets date for fourth-quarter fiscal 2026 earnings release and conference call webcast (GlobeNewswire)
  • Ashland's Growth Rebound Faces A Margin Test As Hopewell Drag Lingers Into Year-End (Earnings Whispers)
  • Loading…
  • Ashland scales Transformed Vegetable Oils technology platform in crop care, launches agrimer eco-disperse OD polymeric dispersant (GlobeNewswire)
  • Ashland Innovation Day to be held September 17, 2026 (GlobeNewswire)
  • Ashland to host Innovation Day for analysts and investors (GlobeNewswire)
  • Ashland advances high-growth oral biologics delivery applications with launch of permexa sodium caprate (GlobeNewswire)
  • Ashland board authorizes quarterly dividend (GlobeNewswire) +5.51%
  • Ashland Inc (ASH) Q3 2026 Earnings Call Highlights: Strong Sales Growth Amidst Profitability ... (GuruFocus.com) +7.10%
  • Ashland: Fiscal Q3 Earnings Snapshot (Associated Press)
  • Ashland reports third quarter 2026 results and reaffirms full-year sales & Adjusted EBITDA outlook (GlobeNewswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q42026-11-031.1201.275-0.350498501.7610
2026Q32026-07-281.0200.9850.348497485.9810
2026Q22026-04-280.9100.9580.348482485.6110
2026Q12026-02-020.2600.260-0.261386400.8710
2025Q42025-11-041.0801.2430.696478482.39
2025Q32025-07-291.0401.205-16.130463476.589
2025Q22025-04-300.9901.1030.681479502.628
2025Q12025-01-280.2800.170-3.511405429.069
2024Q42024-11-061.2601.2820.327522524.078
2024Q32024-08-061.4901.4480.275544574.418
2024Q22024-04-301.2701.1442.353575574.649
2024Q12024-01-300.4500.1970.569473478.759
2023Q42023-11-080.4100.687-0.098518528.579
2023Q32023-07-251.2301.3200.962546559.3811
2023Q22023-05-021.4301.4651.655603625.9612
2023Q12023-01-310.9700.9760.745525526.8912

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2018FY3.5803.5741.7813,7433,735
2019FY2.5052.7028.0162,5002,518
2020FY3.0302.638-8.9342,3262,311
2021FY4.4304.5573.6562,3782,368
2022FY5.7005.641-2.4732,3912,390
2023FY4.0404.3763.3592,1922,201
2024FY4.4504.4513.3802,1002,117
2025FY3.3803.553-18.3701,8241,827
2026FY3.3103.5000.0801,8631,866
2027FY-4.221--1,934
2028FY-4.923--2,016
2029FY-5.502--2,096

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2027Q1S2026-11-06501405.97399411
2027Q1S2026-11-05501405.37396411
2027Q1S2026-11-04401403.97396411.06
2027Q1S2026-11-03300403.61396414
2027Q1S2026-10-14300403.61396414
2027Q1S2026-10-02300404.61396417
2027Q1S2026-09-26401406.34396417
2027Q1S2026-07-31501404.35396417
2027Q1S2026-07-29501404.53396417.88
2027Q1S2026-07-15510405.68394417.88
2027Q1S2026-07-04510405.89394418.9
2027Q1S2026-07-03511405.89394418.9
2027Q1S2026-06-30501404.5394418.9
2027Q1S2026-06-18511404.5394418.9

Estimate history

EPS, annual1.7818.016-8.9343.656-2.4733.3593.38-18.370.087
Period201820192020202120222023202420252026
EPS, quarterly0.327-3.5110.681-16.130.696-0.2610.3480.348-0.348
PeriodQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
Sales, annual258924932016211123912191211318241863
Period201820192020202120222023202420252026
Sales, quarterly522405479463478386482497498
PeriodQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
Shares, annual626060.4715754514746-45.793
Period201820192020202120222023202420252026MRQ
Shares, quarterly4747.18345.69545.7064645.76245.78845.793-
PeriodQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26

Income statement, annual

Currency USD, millions
MetricTTM2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Revenue1,863.001,863.001,824.002,113.002,191.002,391.002,111.002,016.002,493.00
Cost of Goods Sold Incl. D&A1,351.001,322.001,387.001,620.001,670.001,722.001,531.001,501.001,726.00
Gross Profit512.00541.00437.00493.00521.00669.00580.00515.00767.00
Selling, General and Administrative Excl. Other377.00432.00339.00378.00353.00337.00395.00397.00459.00
Research and Development56.0055.0054.0055.0051.0055.0050.0056.0066.00
Other Operating Expense--0.000.000.000.000.000.000.00
Operating Income135.00109.0098.00115.00168.00332.00185.00118.00308.00
Interest Expense72.0040.0063.0055.0057.0066.0073.0091.00118.00
Unusual Expense37.008.00716.0032.009.0044.0022.00642.00137.00
Net Income Before Taxes70.0069.00-809.00-24.00160.00206.00135.00-577.0070.00
Income Taxes45.0044.0013.00-223.00-8.0025.00-38.00-22.0046.00
Consolidated Net Income25.0025.00-822.00199.00168.00181.00173.00-555.0024.00
Net Income From Continuing Operations25.0025.00-822.00199.00168.00181.00173.00-555.0024.00
Net Income4.004.00-845.00169.00178.00-136.00223.00-545.00505.00
EPS (Recurring)0.650.21-7.473.833.41-1.883.91-1.579.54
EPS (Basic, Before Extraordinaries)---18.373.453.36-2.473.72-8.938.15
EPS (Diluted)0.090.09-18.373.383.36-2.473.66-8.938.02
EBITDA353.00294.00386.00444.00468.00640.00480.00402.00559.00
Non-Operating Income (Expense)39.008.00-128.00-52.0058.00-16.0045.0038.0017.00
Other After Tax Adjustments--0.000.000.000.000.000.000.00
Stock Option Compensation Expense--10.0014.0017.0018.0014.0012.0020.00
Price To Earnings Ratio882.87882.87-28.07--24.37-9.36
Price To Sales Ratio1.681.681.212.062.012.222.582.151.95
Gross Margin27.4829.0423.9623.3323.7827.9827.4825.5530.77
Operating Margin7.255.855.375.447.6713.898.765.8512.35
Net Margin0.210.21-46.338.008.12-5.6910.56-27.0320.26
Shares Outstanding--46.0047.0051.0054.0057.0060.4760.00
Market Capitalization3,517.393,517.392,189.774,246.914,185.365,141.625,412.564,288.574,663.22

Income statement, quarterly

Currency USD, millions
Metric2026Q42026Q32026Q22026Q12025Q42025Q32025Q22025Q1
Total Revenue498.00497.00482.00386.00478.00463.00479.00405.00
Cost of Goods Sold Incl. D&A333.00362.00350.00306.00335.00393.00349.00311.00
Gross Profit165.00135.00132.0080.00143.0070.00130.0094.00
Selling, General and Administrative Excl. Other127.0083.0081.0086.0082.0086.00101.0071.00
Research and Development14.0015.0014.0013.0013.0013.0014.0013.00
Other Operating Expense-0.000.000.000.000.000.000.00
Operating Income38.0052.0051.00-6.0061.00-16.0029.0023.00
Interest Expense21.0017.0017.0017.0016.0018.0018.0018.00
Unusual Expense11.0011.0012.003.006.00692.00-4.0020.00
Net Income Before Taxes9.0056.0020.00-15.0064.00-704.0039.00-209.00
Income Taxes26.0015.005.00-1.0031.0015.009.00-43.00
Consolidated Net Income-17.0041.0015.00-14.0033.00-719.0030.00-166.00
Net Income From Continuing Operations-17.0041.0015.00-14.0033.00-719.0030.00-166.00
Net Income-16.0016.0016.00-12.0032.00-742.0032.00-165.00
EPS (Recurring)-0.180.520.53-0.220.79-5.600.62-3.21
EPS (Basic, Before Extraordinaries)-0.350.35-0.260.70-16.130.68-3.51
EPS (Diluted)-0.350.350.35-0.260.70-16.130.68-3.51
EBITDA83.00121.0097.0052.00112.00106.0091.0075.00
Non-Operating Income (Expense)3.0032.00-2.0011.0025.0022.0024.00-194.00
Other After Tax Adjustments-0.000.000.000.000.000.000.00
Stock Option Compensation Expense-4.743.953.951.582.373.953.16
Price To Earnings Ratio882.87------20.29
Price To Sales Ratio1.681.641.411.491.211.241.431.64
Gross Margin33.1327.1627.3920.7329.9215.1227.1423.21
Operating Margin7.6310.4610.58-1.5512.76-3.466.055.68
Net Margin-3.213.223.32-3.116.69-160.266.68-40.74
Shares Outstanding-45.7945.7945.7646.0045.7145.6947.18
Market Capitalization3,517.393,016.962,544.852,684.862,189.772,297.522,797.473,371.51

Balance sheet, annual

Currency USD, millions
Metric2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Cash & Short Term Investments480.00265.00373.00494.00707.00247.00484.00256.00324.00
Short Term Receivables266.00242.00243.00338.00401.00368.00436.00481.00522.00
Inventories482.00568.00545.00626.00629.00473.00506.00597.00596.00
Other Current Assets108.00130.0034.0048.0031.00629.00121.0099.00270.00
Total Current Assets1,336.001,205.001,195.001,506.001,768.001,717.001,547.001,433.001,712.00
Net Property, Plant & Equipment1,233.001,304.001,417.001,495.001,445.001,551.001,611.001,577.001,646.00
Total Investments and Advances248.00300.00298.00293.00316.00388.00306.00316.00320.00
Long-Term Note Receivable137.00139.00143.00142.00155.00147.00149.00169.00179.00
Intangible Assets1,196.001,268.002,132.002,248.002,275.002,529.002,316.003,341.003,489.00
Deferred Tax Assets138.00157.00210.0022.0020.0030.0026.0023.0028.00
Other Assets239.00238.00250.00233.00234.00250.00922.00392.00885.00
Total Assets4,527.004,611.005,645.005,939.006,213.006,612.006,877.007,251.008,259.00
Short Term Debt Incl. Current Port. of LT Debt22.0021.0020.0038.0019.00397.00302.00166.00254.00
Accounts Payable210.00189.00214.00210.00265.00236.00211.00313.00331.00
Other Current Liabilities220.00213.00256.00208.00269.00301.00300.00278.00491.00
Total Current Liabilities452.00423.00490.00456.00553.00934.00813.00757.001,076.00
Long Term Debt1,450.001,469.001,448.001,420.001,364.001,706.001,687.001,501.002,275.00
Provision for Risks Charges462.00664.00688.00692.00732.00786.00820.00848.00915.00
Deferred Tax Liabilities24.0031.0029.00148.00176.00237.00229.00264.00286.00
Other Liabilities291.00120.00122.00126.00168.00197.00292.00310.00301.00
Total Liabilities2,679.002,707.002,777.002,842.002,993.003,860.003,841.003,680.004,853.00
Non-Equity Reserves-0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity1,848.001,904.002,868.003,097.003,220.002,752.003,036.003,571.003,406.00
Total Shareholders Equity1,848.001,904.002,868.003,097.003,220.002,752.003,036.003,571.003,406.00
Accumulated Minority Interest-0.000.000.000.000.000.000.000.00
Total Equity1,848.001,904.002,868.003,097.003,220.002,752.003,036.003,571.003,406.00
Total Liabilities & Stockholders Equity4,527.004,611.005,645.005,939.006,213.006,612.006,877.007,251.008,259.00
Book Value Per Share-41.3961.0260.7359.6348.2850.2159.5254.94
Tangible Book Value Per Share-13.8315.6616.6517.503.9111.913.83-1.34
Full-Time Employees-2,9003,2003,8003,9004,1004,5004,7006,000
Price to Book Ratio1.881.161.431.331.591.851.421.291.54
Return on Assets0.55-16.033.442.762.822.57-7.860.310.23
Return on Equity1.33-34.456.675.326.065.98-16.800.690.56
Return on Invested Capital0.12-25.053.923.94-2.975.00-11.549.962.01
Quick Ratio1.891.511.331.932.061.331.281.101.04
Current Ratio2.962.852.443.303.201.841.901.891.59

Cash flow, annual

Currency USD, millions
MetricTTM2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Net Income4.004.00-2,489.00169.00178.00927.00220.00-508.00505.00
Depreciation185.00185.00237.00274.00243.00241.00244.00235.00289.00
Other Funds (Non Cash)29.0029.002,504.0094.00-37.00-703.00-52.00533.00-457.00
Funds from Operations225.00225.00325.00235.00352.00430.00386.00218.00357.00
Extraordinary Item--0.000.000.000.000.000.000.00
Changes in Working Capital158.00158.00-191.00227.00-58.00-237.0080.009.00-129.00
Cash from Operating Activities383.00383.00134.00462.00294.00193.00466.00227.00228.00
Capital Expenditures-88.00-88.00-98.00-137.00-170.00-113.00-105.00-133.00-154.00
Net Assets From Acquisitions--0.000.000.000.00-309.000.00-2.00
Sale of Fixed Assets and Businesses6.006.0016.000.0011.0051.005.005.009.00
Purchase or Sale of Investments74.0074.0064.0079.0058.0035.0033.0035.0025.00
Purchase of Investments-71.00-71.00-54.00-53.00-47.00-87.00-149.00-21.00-355.00
Sale Or Maturity of Investments145.00145.00118.00132.00105.00122.00182.0056.00380.00
Other Uses-59.00-59.00-53.00-71.00-65.00-78.00-97.00-9.00-2.00
Other Sources29.0029.0028.0027.006.001,255.00186.0086.00986.00
Cash from Investing Activities-38.00-38.00-43.00-102.00-160.001,150.00-287.00-16.00862.00
Cash Dividends Paid-76.00-76.00-76.00-78.00-76.00-70.00-70.00-66.00-64.00
Change in Capital Stock0.000.00-100.00-380.00-300.00-200.00-450.000.00-200.00
Repurchase of Common Pref Stock0.000.00-100.00-380.00-300.00-200.00-450.000.00-200.00
Sale of Common Pref Stock--0.000.000.000.000.000.000.00
Proceedsfrom Stock Options--0.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net--0.00-16.0016.00-615.00101.0082.00-875.00
Change in Long Term Debt--0.000.000.00-250.0017.00-33.00-797.00
Issuance of Long Term Debt--0.000.000.000.00444.00793.000.00
Reduction of Long Term Debt--0.000.000.00-250.00-427.00-826.00-797.00
Net Financing Active Other Cash Flow-3.00-3.00-3.00-5.00-11.00-9.00-7.00-7.00-10.00
Other Financing Activities Uses-3.00-3.00-3.00-5.00-11.00-9.00-7.00-7.00-10.00
Cash from Financing Activities-79.00-79.00-179.00-479.00-371.00-896.00-426.009.00-1,149.00
Exchange Rate Effect-1.00-1.003.002.008.00-11.003.002.00-3.00
Net Change in Cash265.00265.00-85.00-117.00-229.00436.00-244.00222.00-62.00
Free Cash Flow295.00295.0036.00325.00124.0080.00361.0094.0074.00
Preferred Dividends (Cash Flow)--0.000.000.000.000.000.000.00
Price to Free Cash Flow14.2714.27-17.6191.89531.8318.68154.50485.42
Deferred Taxes & Investment Tax Credit-7.0073.00-302.00-32.00-35.00-26.00-42.0020.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q42026Q32026Q22026Q12025Q42025Q3
Cash & Short Term Investments480.00487.00393.00354.00265.00274.00
Short Term Receivables266.00256.00244.00190.00242.00201.00
Inventories482.00490.00506.00565.00568.00567.00
Other Current Assets108.0059.0066.0045.00130.0082.00
Total Current Assets1,336.001,292.001,209.001,154.001,205.001,124.00
Net Property, Plant & Equipment1,233.001,249.001,264.001,281.001,304.001,302.00
Total Investments and Advances248.00285.00276.00297.00300.00283.00
Intangible Assets1,196.001,213.001,229.001,255.001,268.001,283.00
Deferred Tax Assets138.00157.00157.00157.00157.00241.00
Other Assets239.00243.00242.00251.00238.00259.00
Total Assets4,527.004,578.004,499.004,519.004,611.004,621.00
Short Term Debt Incl. Current Port. of LT Debt22.0018.0019.0019.0021.0019.00
Accounts Payable210.00198.00181.00167.00189.00185.00
Other Current Liabilities220.00208.00195.00180.00213.00216.00
Total Current Liabilities452.00424.00395.00366.00423.00420.00
Long Term Debt1,450.001,458.001,459.001,470.001,469.001,466.00
Provision for Risks Charges462.00671.00629.00650.00664.00700.00
Deferred Tax Liabilities24.0031.0031.0031.0031.0028.00
Other Liabilities291.00124.00119.00124.00120.00118.00
Total Liabilities2,679.002,708.002,633.002,641.002,707.002,732.00
Non-Equity Reserves-0.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity1,848.001,870.001,866.001,878.001,904.001,889.00
Total Shareholders Equity1,848.001,870.001,866.001,878.001,904.001,889.00
Accumulated Minority Interest-0.000.000.000.000.00
Total Equity1,848.001,870.001,866.001,878.001,904.001,889.00
Total Liabilities & Stockholders Equity4,527.004,578.004,499.004,519.004,611.004,621.00
Book Value Per Share-40.8440.7541.0441.3941.33
Tangible Book Value Per Share-14.3513.9113.6113.8313.26
Full-Time Employees----2,900-
Price to Book Ratio1.881.621.361.421.160.90
Return on Assets0.551.63-14.08-13.74-16.03-16.13
Return on Equity1.333.99-30.96-29.98-34.45-34.43
Return on Invested Capital-0.490.480.48-0.360.95-22.12
Quick Ratio1.891.891.781.611.511.33
Current Ratio2.963.053.063.152.852.68

Cash flow, quarterly

Currency USD, millions
Metric2026Q42026Q32026Q22026Q12025Q42025Q3
Net Income-16.0016.0016.00-12.0098.00-2,180.00
Depreciation44.0048.0045.0048.0050.0076.00
Other Funds (Non Cash)37.00-3.005.00-10.00-91.002,147.00
Funds from Operations68.0062.0068.0027.00125.0047.00
Extraordinary Item-0.000.000.000.000.00
Changes in Working Capital22.0056.00-18.0098.00-85.0068.00
Cash from Operating Activities90.00118.0050.00125.0040.00115.00
Capital Expenditures-37.00-20.00-17.00-14.00-34.00-20.00
Net Assets From Acquisitions-0.000.000.000.000.00
Sale of Fixed Assets and Businesses0.002.000.004.00-11.000.00
Purchase or Sale of Investments22.0019.0018.0015.0023.0016.00
Purchase of Investments-31.00-13.00-15.00-12.00-18.00-12.00
Sale Or Maturity of Investments53.0032.0033.0027.0041.0028.00
Other Uses-18.00-8.00-9.00-24.00-17.00-9.00
Other Sources4.005.0015.005.0023.005.00
Cash from Investing Activities-29.00-2.007.00-14.00-16.00-8.00
Cash Dividends Paid-19.00-19.00-19.00-19.00-19.00-19.00
Preferred Dividends (Cash Flow)-0.000.000.000.000.00
Change in Capital Stock0.000.000.000.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock-0.000.000.000.000.00
Proceedsfrom Stock Options-0.000.000.000.000.00
Issuance or Reduction of Debt, Net-0.000.000.000.00-50.00
Change in Long Term Debt-0.000.000.000.000.00
Issuance of Long Term Debt-0.000.000.000.000.00
Reduction of Long Term Debt-0.000.000.000.000.00
Net Financing Active Other Cash Flow-2.001.000.00-2.001.00-1.00
Other Financing Activities Uses-2.001.000.00-2.001.00-1.00
Cash from Financing Activities-21.00-18.00-19.00-21.00-18.00-70.00
Exchange Rate Effect0.00-1.001.00-1.002.002.00
Net Change in Cash40.0097.0039.0089.008.0039.00
Free Cash Flow53.0098.0033.00111.006.0095.00
Price to Free Cash Flow14.2717.6215.1421.76--

Revenue breakdown

Non-US2025: 1.36B
United States2025: 464.00M
Consolidation, Policy2025: -42.00M
Intermediates And Solvents2025: 137.00M
Life Sciences2025: 641.00M
Personal Care And Household2025: 577.00M
Specialty Additives2025: 511.00M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3011.23%5.1M45.2M595.04K
2026-10-1511.22%5.1M45.2M672.28K
2026-09-3010.23%4.6M45.2M677.33K
2026-09-159.74%4.4M45.2M790.65K
2026-08-3110.66%4.8M45.2M876.93K
2026-08-149.43%4.3M45.2M962.48K
2026-07-319.91%4.5M45.2M1.03M
2026-07-1512.60%5.7M45.2M1.03M
2026-06-3012.69%5.7M45.2M1.03M
2026-06-1512.45%5.6M45.1M922.81K
2026-05-2912.18%5.5M45.2M825.70K
2026-05-1511.37%5.1M45.2M799.12K
2026-04-3012.40%5.6M45.2M733.47K
2026-04-1512.12%5.5M45.1M673.21K
2026-03-3110.82%4.9M45.1M691.01K
2026-03-1311.07%5.0M45.1M683.70K
2026-02-2711.13%5.0M45.1M786.72K
2026-02-139.35%4.2M45.1M790.07K
2026-01-308.63%3.9M45.1M825.97K
2026-01-158.46%3.8M45.1M834.20K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call35.0040.3043.800.004.0830.000.000.981-0.0740.006
call40.0035.3038.800.003.5000.000.000.948-0.1950.013
call45.0030.4033.800.002.9870.000.000.938-0.1880.015
call50.0025.1029.000.002.6520.000.000.927-0.1810.017
call55.0020.4023.800.002.1020.000.000.903-0.1960.022
call60.0015.1018.900.001.7400.000.000.881-0.1820.025
call65.0010.7013.9013.101.3571000.000.827-0.2000.032
call70.005.909.108.101.0281980.000.765-0.1750.039
call75.001.754.103.600.6207590.000.626-0.1330.048
call80.000.002.550.750.76422.000.000.389-0.1780.048
call85.000.002.150.400.9922520.000.296-0.2210.044
call90.000.002.150.201.4703.000.000.314-0.3340.046
call95.000.002.150.151.7091.000.000.285-0.3710.044
call1000.002.150.001.9220.000.000.263-0.4010.042
put35.000.000.250.002.4630.000.00-0.018-0.0670.006
put40.000.002.150.002.8570.000.00-0.052-0.1940.013
put45.000.001.200.002.4220.000.00-0.061-0.1870.015
put50.000.000.950.302.0302.000.00-0.073-0.1790.017
put55.000.001.150.501.7664.000.00-0.097-0.1930.022
put60.000.001.151.301.41511.000.00-0.118-0.1790.025
put65.000.001.550.101.2091020.00-0.172-0.1970.032
put70.000.001.751.550.86715.000.00-0.235-0.1710.039
put75.000.001.601.400.47556.000.00-0.382-0.1290.048
put80.001.554.900.000.6020.000.00-0.610-0.1730.048
put85.006.1010.100.000.9510.000.00-0.704-0.2150.044
put90.0011.1015.100.001.2050.000.00-0.747-0.2500.040
put95.0016.1020.100.001.4270.000.00-0.775-0.2770.038
put10021.1025.100.001.6260.000.00-0.794-0.2980.036

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-038-KCurrent report2026-11-03SEC
2026-10-30SCHEDULE 13G/ASEC
2026-10-28SCHEDULE 13G/ASEC
2026-10-014Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-09-258-KCurrent report2026-09-24SEC
2026-09-234Statement of changes in beneficial ownership of securities2026-09-21SEC
2026-09-164Statement of changes in beneficial ownership of securities2026-09-15SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-11SEC
2026-08-12SCHEDULE 13G/ASEC
2026-08-108-K/A2026-07-27SEC
2026-08-054Statement of changes in beneficial ownership of securities2026-07-27SEC
2026-08-054Statement of changes in beneficial ownership of securities2026-07-27SEC
2026-08-053Initial statement of beneficial ownership of securities2026-07-27SEC
2026-08-053Initial statement of beneficial ownership of securities2026-07-27SEC
2026-08-05SCHEDULE 13GSEC
2026-07-31SCHEDULE 13GSEC
2026-07-318-KCurrent report2026-07-30SEC
2026-07-304Statement of changes in beneficial ownership of securities2026-07-29SEC
2026-07-2910-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-294Statement of changes in beneficial ownership of securities2026-07-27SEC
2026-07-288-KCurrent report2026-07-27SEC
2026-07-288-KCurrent report2026-07-28SEC
2026-07-28SCHEDULE 13GSEC
2026-07-08SCHEDULE 13G/ASEC
2026-07-014Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-06-1711-KAnnual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)2025-12-31SEC
2026-06-1711-KAnnual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)2025-12-31SEC
2026-06-1711-KAnnual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)2025-12-31SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
BlackRock, Inc.12.48%
Standard Investments LLC9.88%
FRANKLIN RESOURCES INC7.90%
DIMENSIONAL FUND ADVISORS LP5.74%
VANGUARD PORTFOLIO MANAGEMENT LLC5.38%
VANGUARD CAPITAL MANAGEMENT LLC4.51%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/4.45%
FRONTIER CAPITAL MANAGEMENT CO LLC4.37%
Ancora Advisors LLC4.25%
COOPERMAN LEON G4.14%

Funds

Fund% owned
PGIM High Yield Fund79.42%
DFA Global Core Plus Fixed Income Portfolio26.36%
PGIM Total Return Bond Fund24.33%
Loomis Sayles Strategic Income Fund23.78%
BrandywineGLOBAL - CORPORATE CREDIT FUND18.63%
Columbia Strategic Income Fund14.31%
Federated Hermes Institutional High Yield Bond Fund14.14%
iShares Broad USD High Yield Corporate Bond ETF11.53%
DWS High Income Fund11.05%
Columbia High Yield Bond Fund9.35%

OakChart. ASH. Cached 15 minutes.